2019
Harnessing the power of social media: how can it help in axial spondyloarthritis research?
Reuter K, Danve A, Deodhar A. Harnessing the power of social media: how can it help in axial spondyloarthritis research? Current Opinion In Rheumatology 2019, 31: 321-328. PMID: 31045949, DOI: 10.1097/bor.0000000000000614.Peer-Reviewed Original ResearchConceptsChronic inflammatory rheumatic diseasesInflammatory rheumatic diseasesPatient-generated health dataDelivery of careMiddle-aged adultsMost patientsAxSpA patientsRheumatic diseasesStudy enrollmentAxial spondyloarthritisDisease experienceHealth educationSpondyloarthritis ResearchStudy participantsClinical researchStudy designPatientsRheumatologyHealth dataPromising studiesFurther explorationSpondyloarthritisAxSpARheumatologists
2017
Treat to Target in Axial Spondyloarthritis: What Are the Issues?
Danve A, Deodhar A. Treat to Target in Axial Spondyloarthritis: What Are the Issues? Current Rheumatology Reports 2017, 19: 22. PMID: 28386759, DOI: 10.1007/s11926-017-0648-6.Peer-Reviewed Original ResearchConceptsT2T strategyAxial spondyloarthritisT2TPsoriatic Arthritis TrialRandomized clinical studyChronic medical conditionsLimited therapeutic optionsRoutine clinical practiceT strategyLack of evidenceAggressive managementPsoriatic arthritisRadiographic outcomesRheumatic diseasesRheumatoid arthritisClinical evidenceTherapeutic optionsArthritis trialsClinical trialsClinical studiesMedical conditionsClinical practiceTarget strategyArthritisSpondyloarthritisComorbidities in Spondyloarthritis
Danve A, Raychaudhuri S. Comorbidities in Spondyloarthritis. Current Treatment Options In Rheumatology 2017, 3: 63-74. DOI: 10.1007/s40674-017-0061-3.Peer-Reviewed Original ResearchHealth care costsCertain comorbiditiesCommon comorbiditiesGastroduodenal ulcersSpA patientsComorbid conditionsSleep apneaVertebral fracturesLung diseaseMyocardial infarctionInflammatory diseasesCardiovascular diseaseComprehensive carePeripheral skeletonCare costsHealth outcomesComorbiditiesDiseasePatientsHypertensionApneaRheumatologistsSpondyloarthritisInfarctionUlcers
2015
IL-17 Inhibition in Axial Spondyloarthritis
Danve A, Deodhar A. IL-17 Inhibition in Axial Spondyloarthritis. Current Treatment Options In Rheumatology 2015, 1: 221-230. DOI: 10.1007/s40674-015-0020-9.Peer-Reviewed Original ResearchIL-23/ILIL-17IL-23Monoclonal antibodiesExtra-articular manifestationsTNF-α blockadeIL-17 inhibitionIL-23 receptorQuality of lifeSignificant beneficial effectDisease activityProspective trialRadiographic progressionInhibitor medicationIL-12MRI scoresPhysical functionAxial spondyloarthritisClinical studiesP40 subunitAnimal modelsBeneficial effectsWestern populationsNovel optionSpondyloarthritis